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Diminished exposure to harmless micro-organisms, such as lactobacilli, has been suggested to play a
role in the increased prevalence of allergic disorders in Westernized communities. The development of
allergies depends on both environmental factors and genetic variations, including polymorphisms in
genes encoding pattern recognition receptors. The present study examines the effects of both
colonization with specific Lactobacillus species and genetic variations in DC-SIGN, a pattern
recognition receptor on dendritic cells that recognizes lactobacilli, on the development of atopic
dermatitis (AD) and sensitization in infancy. Within the KOALA Birth Cohort Study, faecal samples of
681 one-month-old infants were collected and quantitatively screened for five Lactobacillus species:
L. casei, L. paracasei, L. rhamnosus, L. acidophilus and L. reuteri. Eleven haplotype-tagging
polymorphisms in the DC-SIGN gene were genotyped in these children. Allergic outcomes were a
clinical diagnosis of AD and sensitization (specific IgE) at age 2 years. L. rhamnosus (31.5 %), L.
paracasei (31.3 %) and L. acidophilus (14.4 %) were frequently detected in the faecal samples of
one-month-old infants, whereas L. casei (2.5 %) and L. reuteri (,1 %) were rare. Colonization with L.
paracasei decreased the risk of AD significantly (odds ratio 0.57, 95 % confidence interval 0.32–
0.99), whereas effects of L. acidophilus were of borderline statistical significance (0.46, 0.20–1.04).
Two DC-SIGN polymorphisms, rs11465413 and rs8112555, were statistically significantly
associated with atopic sensitization. The present study supports the ‘old friends’ hypothesis
suggesting that certain health-beneficial micro-organisms protect us from developing allergies and
that these protective effects are species-dependent. Firm conclusions on the potential interaction
between lactobacillus colonization and genetic variations in DC-SIGN in association with the
development of allergic disorders cannot be drawn, given the limited power of our study. Therefore,
incorporation of consecutive faecal sampling in newly started (birth) cohort studies would be a first
requisite to further increase our understanding of host–microbial interactions in health and disease.
Abbreviations: AD, atopic dermatitis; CI, confidence interval; DC, dendritic cell; DC-SIGN, DC-specific ICAM-3-grabbing non-integrin; LD, linkage
disequilibrium; OR, odds ratio; SNP, single-nucleotide polymorphism.
Microbiology (2010), 156, 3298–3305 DOI 10.1099/mic.0.042069-0
3298 042069 G 2010 SGM Printed in Great Britain
INTRODUCTION
The ‘old friends’ hypothesis is one of the most popular
explanations for the increase in prevalence of asthma and
allergies in the past decades. It implies that the increase in
allergic (atopic) disorders in Westernized communities is
(partly) explained by diminished exposure to harmless
micro-organisms (‘old friends’) like lactobacilli (Rook
et al., 2004; Rook & Brunet, 2005). These micro-organisms
are thought to prime immune regulation. Particularly, the
modulation of antigen-presenting cell function by these
micro-organisms and consequently the induction of regu-
latory T (Treg) cells are considered important (Boirivant &
Strober, 2007; Rook & Brunet, 2005). Dendritic cells (DCs)
are antigen-presenting cells that play an essential role in
mucosal tolerance. Depending on the microbial stimulus
encountered, DCs secrete cytokines that dictate specific
differentiation of unprimed, naı̈ve CD4+ T cells toward
Th1, Th2, Th17 or Treg cell responses (Geijtenbeek et al.,
2009; Mohamadzadeh et al., 2005).
Epidemiological evidence for a protective effect of
indigenous lactobacilli on allergic disorders is inconsis-
tent. The first study comparing intestinal microbiota of 2-
year-old children with and without atopic dermatitis (AD)
showed a lower prevalence of lactobacilli in the faeces of
children with the disease (Björkstén et al., 1999). Pertur-
bation in the gut microbiota of allergic children was
confirmed in many subsequent studies, but none of these
studies showed differences in the prevalence of intestinal
lactobacilli (Penders et al., 2007a). The quantification of
lactobacilli within these studies was limited to the genus
level. As different species of lactobacilli induce distinct
and even opposing immune responses (Christensen et al.,
2002), the potential species-specific effects of lactobacilli
in the aetiology of allergic disorders may thus have been
overlooked. Indeed a recent study that differentiated
between group I and II lactobacilli reported that children
who developed allergy were significantly less colonized
with group I lactobacilli (L. rhamnosus, L. paracasei and L.
casei) during their first months of life (Sjögren et al.,
2009).
However, the development of allergic diseases depends not
only on environmental factors (like microbial stimulation)
but also on genetic factors. Genes involved in microbial
recognition, binding and subsequent immune signalling may
be important candidates in this respect. The C-type lectin
receptor DC-specific ICAM-3-grabbing non-integrin (DC-
SIGN) is of special interest regarding the recognition and
binding of Lactobacillus species. Smits et al. (2005) showed
that L. reuteri and L. casei, but not L. plantarum, bind to DC-
SIGN and prime monocyte-derived DCs to drive the
development of IL-10-producing Treg cells. Recently, it was
demonstrated that L. acidophilus NCFM (North Carolina
Food Microbiology) attaches to DCs and induces a
concentration-dependent production of IL-10 and low
IL12p70. It was further shown that the cellular contacts of
DCs and L. acidophilus involve a specific interaction between
DC-SIGN and surface layer protein A of this species
(Konstantinov et al., 2008).
Genetic variations in the DC-SIGN receptor have been
shown to influence the susceptibility to several infectious
agents such as Mycobacterium tuberculosis (Selvaraj et al.,
2009; Vannberg et al., 2008), human immunodeficiency
virus-1 (Liu et al., 2004; Martin et al., 2004; Selvaraj et al.,
2009) and dengue virus (Sakuntabhai et al., 2005). To our
knowledge, no studies have so far examined variations in
DC-SIGN in association with allergic diseases.
To gain more insight into the species-specific effects of
indigenous lactobacilli on the aetiology of allergic diseases,
we studied the association between colonization with specific
Lactobacillus species in early infancy and the development of
AD and allergic sensitization in the first 2 years of life.
Furthermore, we assessed effects of genetic variations in DC-
SIGN on the development of these atopic outcomes.
METHODS
Design. This study was conducted within the KOALA Birth Cohort
Study, a prospective cohort in the Netherlands, described in detail
elsewhere (Kummeling et al., 2005). Briefly, 2834 pregnant women
were recruited at 34 weeks of gestation. During pregnancy and early
childhood, data on perinatal determinants of the child’s health as well
as on hygiene, infections, nutrition, child rearing and other lifestyle
characteristics were collected for all members of the cohort by
repeated questionnaires at 34 weeks of gestation and 3, 7, 12 and 24
months post-partum. The study was approved by the medical ethics
committee of Maastricht University. Written informed parental
consent was obtained for all participants.
Recruitment of the subcohort. This study investigated all children
for whom both a faecal sample, at age 1 month, and a buccal swab
sample were available.
All participating parents were asked to provide a buccal swab sample
of their child for genotyping, whereas only those participants
recruited from January 2002 onwards were asked to consent to
sample their child’s faeces. After exclusion of premature infants,
infants receiving antimicrobial agents during their first month of life,
or those having insufficient or no faeces (,1 g) collections between
the ages of 3 and 6 weeks post-partum, and infants without faeces
questionnaires, 681 children were eligible for analyses.
When the children reached the age of 2 years, the parents of 506 of the
681 children consented to a home visit for a physical examination of
the child for AD and the collection of venous blood samples to
determine specific and total IgE levels.
Faecal microbiota composition. The collection and processing of
faecal samples has been described in detail elsewhere (Penders et al.,
2007b). Briefly, parents collected a faecal sample by placing a sanitary
napkin in the diaper (to prevent absorption of the faeces by the
diaper), collected the faeces out of the napkin into the collection tube
and sent it immediately to our laboratory by post. At the laboratory
faecal samples were diluted tenfold in peptone-water (Oxoid
CM0009) containing 20 % (v/v) glycerol (Merck) and stored at
–20 uC until analysis. DNA was extracted by a combination of bead-
beating and the QIAamp DNA Stool Mini kit. For the present study,
faecal samples were subjected to real-time PCRs for the enumeration
of total lactobacilli, L. casei, L. paracasei, L. reuteri, L. rhamnosus and
L. acidophilus.
Lactobacilli and DC-SIGN in the aetiology of allergies
http://mic.sgmjournals.org 3299
L. paracasei, L. acidophilus and L. rhamnosus were selected because of
their relatively high prevalence in this age group compared to other
Lactobacillus species (Ahrné et al., 2005; Haarman & Knol, 2006;
Mitsou et al., 2008; Savino et al., 2005). L. casei and L. reuteri were less
prevalent in these studies, but were additionally selected because of
their proven interaction with DC-SIGN (Smits et al., 2005).
For the quantitative detection of L. reuteri, L. casei and L. paracasei, 59-
nuclease assays were used as described by Haarman & Knol (2006) with
slight modifications in primer and probe concentrations. Briefly,
amplifications were conducted in a total volume of 25 ml, containing
16 TaqMan Universal PCR Master Mix (Applied Biosystems), 300 nM
of both primers, 100 nM TaqMan MGB-probe, and 2 ml purified target
DNA. The amplification (2 min at 50 uC, 10 min at 95 uC, followed by
42 cycles of 15 s at 95 uC and 1 min at 60 uC) and detection were
conducted with the ABI Prism 7000 sequence detection system.
For the quantification of L. acidophilus, L. rhamnosus and total
lactobacilli, real-time detection of PCR products was conducted with
SYBR Green I (primers listed in Table 1). For L. acidophilus and L.
rhamnosus, amplifications were conducted in a total volume of 25 ml,
containing 16 iQ SYBR Green Supermix (Bio-Rad), 2 ml purified
target DNA and 100 nM of both primers for L. rhamnosus or 300 nM
of both primers for L. acidophilus. The amplification (5 min at 95 uC,
followed by 45 cycles of denaturation at 95 uC for 15 s, binding and
extension for 1 min at 62 uC for L. rhamnosus or at 60 uC for L.
acidophilus) and detection were conducted with the MyiQ Single-
colour real-time PCR Detection System (Bio-Rad). For total lactoba-
cilli, amplifications were conducted in a total volume of 25 ml,
containing 16 iQ SYBR Green Supermix (Bio-Rad), 5 ml purified
target DNA and 500 nM of both primers. The amplification was
conducted as follows: 5 min at 95 uC, followed by 35 cycles consisting
of 15 s at 95 uC, 20 s at 58 uC, 45 s at 72 uC, with a final extension step
at 72 uC for 5 min. Following amplification, melt curve analysis was
performed from 60 to 95 uC using increments of 0.5 uC per 10 s.
Samples were considered to be positive when threshold cycle (Ct)
values were below 35 for total lactobacilli and below 42 for the
species-specific PCRs .
Measurement of infants’ specific IgE. Venous blood samples were
collected from the infants during a home visit at 2 years post-partum.
They were analysed for specific IgE against hen’s eggs, cow’s milk,
peanuts, birch, grass pollen, cat, dog and house dust mite using a
radioallergosorbent test (RAST) as described earlier (Aalberse et al.,
1981). The detection limit for specific IgE was 0.10 IU ml21.
Definition of atopic dermatitis (AD) and sensitization. Children
were defined as having AD according to the UK Working Party (UK-
WP) criteria (Williams et al., 1994) as determined by a trained
research nurse during the home visit at the age of 2 years. The
presence of AD was diagnosed from the presence of four clinical
symptoms: 1, presence of itchy rash; 2, history of flexural dermatitis;
3, visible flexural dermatitis; and 4, onset before the age of 2 years. As
described previously (Penders et al., 2007b), infants with a UK-WP
probability score of AD .90 % were regarded as having AD.
Infants were classified as having allergic sensitization when serum IgE
levels were .0.3 IU ml21 for one or more of the tested food or
inhalant allergens.
DNA collection and processing, SNP selection and genotyping.
Parents were asked to collect buccal swabs, as source of DNA, from
their children. Genomic DNA was extracted from these swabs by
standard methods (Sambrook & Russell, 2001). DNA was amplified
by using REPLI-g UltraFast technology (Qiagen).
Haplotype-tagging SNPs were selected from the publicly available
database on the Innate Immunity website (Lazarus et al., 2002).
Genotyping was performed by competitive allele-specific PCR using
KASPar genotyping chemistry, performed under contract by K-
Biosciences with extensive quality control as described previously
(Bottema et al., 2008).
Statistical analysis. The prevalence of AD and allergic sensitization
was calculated according to colonization with the specific
Lactobacillus species. x2 tests were used to test for differences in the
prevalence of the atopic outcomes between colonized and uncolo-
nized subjects.
Table 1. Primers and probes used in this study
Target organism (amplicon size) Primer/probe Sequence (5§–3§) Tm (6C) Reference
Lactobacillus reuteri (93 bp) Forward primer ACCGAGAACACCGCGTTATTT 59 Haarman & Knol
(2006)
Reverse primer CATAACTTAACCTAAACAATCAAAGATTGTCT 59
Probe 6-FAM-ATCGCTAACTCAATTAAT-MGBNFQ 69
Lactobacillus acidophilus (124 bp) Forward primer GATCGCATGATCAGCTTATA 52 Furet et al. (2004)
Reverse primer AGTCTCTCAACTCGGCTATG 53
Lactobacillus rhamnosus (116 bp) Forward primer TGCTTGCATCTTGATTTAATTTTG 52 Byun et al. (2004)
Reverse primer GGTTCTTGGATYTATGCGGTATTAG 54
Lactobacillus paracasei (80 bp) Forward primer ACATCAGTGTATTGCTTGTCAGTGAATAC 60 Haarman & Knol
(2006)
Reverse primer CCTGCGGGTACTGAGATGTTTC 60
Probe 6-FAM- TGCCGCCGGCCAG-MGBNFQ 70
Lactobacillus casei (132 bp) Forward primer CTATAAGTAAGCTTTGATCCGGAGATTT 59 Haarman & Knol
(2006)
Reverse primer CTTCCTGCGGGTACTGAGATGT 59
Probe 6-FAM-ACAAGCTATGAATTCACTTGC-MGBNFQ 70
Lactobacillus spp. (341 bp) Forward primer AGCAGTAGGGAATCTTCCA 59 Rinttilä et al.
(2004)
Reverse primer CACCGCTACACATGGAG 59
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Linkage disequilibrium (LD) was calculated using Haploview 4.1
(http://www.broad.mit.edu/mpg/haploview), by determining D9 and
r2 values. Genotype distribution was tested for deviations (P,0.05)
from Hardy–Weinberg equilibrium using x2 analyses.
We used x2 tests to analyse whether DC-SIGN SNPs were associated
with AD and allergic sensitization by using a co-dominant model.
Unadjusted and adjusted odds ratios (ORs) and 95 % confidence
intervals for the association between Lactobacillus species colonization
and atopic outcomes according to the different genotypes were
calculated by means of logistic regression. The adjusted regression
models included the following potential confounders: 1, parental atopic
history, defined as self-reported doctor’s diagnosed eczema, hay fever,
asthma, pet and/or house dust mite allergy (both parents non-atopic; at
least one parent atopic); 2, siblings atopic history, defined as parentally
reported doctor’s diagnosed food allergy, eczema, hay fever, asthma,
pet and/or house dust mite allergy (no siblings; ¢1 siblings, all none-
atopic; or ¢1 siblings, at least one atopic); 3, age at collection of faecal
sample (age in days); 4, infant’s sex (boy; girl); 5, pet exposure at home
(no pet exposure; only cat exposure; only dog exposure; only other
furry pet exposure; combination of cat, dog and/or other furry
pet exposure); 6, recruitment group (alternative; conventional)
(Kummeling et al., 2005).
To test whether the effect of Lactobacillus species was modified by
host genotype, an interaction term of genotype and Lactobacillus
species colonization was included in the logistic regression models
and compared to the models without the interaction terms using the
likelihood ratio test. All analyses were performed using SPSS 15.0
statistical software and results were considered statistically significant
at P,0.05. To control for multiple testing, we calculated the false
discovery rate (FDR) for the tests for interaction (based on 33 tests for
interaction per outcome) according to Benjamini & Hochberg (1995).
The P-values were tested for significance at a FDR (q-value) of 0.05.
RESULTS
Intestinal colonization by lactobacilli and allergic
manifestations
The prevalence of the Lactobacillus species in the current
study population was as follows: L. rhamnosus 31.5 %, L.
paracasei 31.3 %, L. acidophilus 14.4 %, L. casei 2.5 % and L.
reuteri ,1 %. Because of the low prevalence of L. casei and
L. reuteri in our population, these bacteria were not taken
into account for further analysis.
Information on AD was available for all 506 children that
were visited at home, whereas information on atopic
sensitization was available for 492 children.
The risk of AD at age 2 years was significantly lower in
children who were colonized with L. paracasei [odds ratio
(OR) 0.57, 95 % confidence interval (CI) 0.32–0.99, P50.04]
compared with those not colonized. For L. acidophilus a
borderline statistically significant decreased risk of AD was
found (OR 0.46, 95 % CI 0.20–1.04) (P50.06). Neither of
these species, nor L. rhamnosus, were however associated
with the risk of atopic sensitization (Table 2).
DC-SIGN gene variants
Eleven DC-SIGN SNPs were genotyped (Table 3), all of
which were in Hardy–Weinberg equilibrium. Strong LD,
with D9 approaching the value of 1 (Fig. 1), was observed
for rs7252229, rs2287886, rs4804803, rs735239, rs735240,
rs11465360, rs7359874 and rs4804804.
Table 4 presents the association between these SNPs and
the atopic outcomes under study. None of the SNPs were
associated with AD. Two SNPs, rs11465413 and rs8112555,
were statistically significantly associated with atopic
sensitization. Of the children who were heterozygous for
rs11465413, 17.9 % were sensitized at the age of 2 years as
compared to 30.0 % of the homozygotes for the major
allele (P50.04). Heterozygotes for rs8112555 were also at
decreased risk of developing atopic sensitization as
Table 2. Prevalence of allergic sensitization and AD according
to Lactobacillus species colonization




L. paracasei No 28.4 (95/334) 18.1 (62/343)
Yes 28.0 (44/157) 11.1 (18/162)
P50.92 P50.04
L. rhamnosus No 27.3 (92/337) 15.3 (53/347)
Yes 30.1 (46/153) 17.2 (27/157)
P50.53 P50.58
L. acidophilus No 28.0 (116/415) 17.1 (73/426)
Yes 31.2 (24/77) 8.8 (7/80)
P50.57 P50.06
Lactobacillus spp. No 28.0 (94/336) 15.7 (54/345)
Yes 29.5 (46/156) 16.1 (26/161)
P50.73 P50.89
*AD according to UK Working Party criteria.
Table 3. Selected DC-SIGN SNPs and minor allele frequen-
cies in the study population






rs11465360 C : A 0.05 0.39
rs11465413 T : A 0.09 0.42
rs11465421 A : C 0.47 0.35
rs2287886 G : A 0.36 0.51
rs4804803 A : G 0.19 0.57
rs4804804 G : A 0.36 0.41
rs7252229 G : C 0.13 0.96
rs735239 A : G 0.34 0.86
rs735240 G : A 0.44 0.86
rs7359874 A : T 0.49 0.45
rs8112555 G : A 0.14 0.84
*Minor alleles first.
DAs determined by x2 test.
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compared to children homozygotic for the major alleles of
this SNP (P50.03).
Gene–environment interaction
To examine whether the associations between colonization
with the Lactobacillus species and atopic outcomes were
modified by genetic variations in DC-SIGN, we examined
these associations stratified for DC-SIGN genotype, and
tested for statistical interaction (test for differences of odds
ratios between strata of DC-SIGN genotypes). The only
statistically significant interaction (P for interaction50.03)
was found between L. rhamnosus colonization and
rs11465360. L. rhamnosus colonization was associated with
an increased risk of AD in homozygotes for the major allele
(CC) (OR 1.63, 0.93–2.84) and with a decreased risk in
heterozygotes (CA) (OR 0.17, 0.02–1.35); however, this
interaction did not withstand correction for multiple
testing.
DISCUSSION
We examined the effect of common intestinal Lactobacillus
species in early infancy and genetic variations in DC-SIGN
in association with development of AD and allergic
sensitization in early childhood within the KOALA birth
cohort.
Colonization by L. acidophilus was associated with a
statistically significant decreased risk of AD, whereas effects
of L. paracasei were of borderline significance. These
findings are in agreement with the ‘old friends’ hypothesis
suggesting that certain health-beneficial micro-organisms
may protect us from developing allergies and that these
effects are species-dependent.
However, we did not find any effect of L. acidophilus and L.
paracasei colonization on atopic sensitization.
No previous observational studies have examined the
association of specific Lactobacillus species, but the effects
of L. paracasei and L. acidophilus supplementation on the
primary prevention of (atopic) dermatitis have been
studied in randomized controlled trials. In agreement with
our study, the trial by West et al. (2009) demonstrated that
L. paracasei supplementation in early infancy reduced the
incidence of eczema but did not influence atopic
sensitization. Indeed, the role of allergic sensitization in
childhood AD remains far from clear. It is neither a
prerequisite nor a uniform cause of the disease (Williams &
Flohr, 2006).
In contrast to the above results, however, L. acidophilus
(LAVRI-A1) supplementation in high-risk newborns failed
to reduce the incidence of eczema as compared to placebo
(Taylor et al., 2007).
As a pattern recognition receptor, DC-SIGN interacts with
a plethora of, mainly pathogenic, micro-organisms other
than lactobacilli (Geijtenbeek et al., 2000). DC-SIGN is
organized into three domains: an N-terminal cytoplasmic
region, a neck region containing eight repeats of a 23 aa
sequence, and a C-terminal C-type lectin domain (Soilleux
et al., 2000). The CD209 gene is located on chromosome
19p13.2-3 and is highly polymorphic.
In the present study, two DC-SIGN SNPs (rs11465413 and
rs8112555) were associated with atopic sensitization.
Homozygotes for the major allele of these SNPs had a
significantly higher risk of sensitization than heterozygous
children. Because of the low minor allele frequency of both
SNPs, the risk of sensitization in children homozygous for
the minor allele could not be examined.
Since this is the first study in which the association between
DC-SIGN gene variants and atopic disorders has been
studied, it would be worthwhile to examine whether these
associations could be confirmed in another population. To
Fig. 1. Position and linkage disequilibrium of
the SNPs within DC-SIGN. (a) DC-SIGN is
located on chromosome 19 (19p13). Eleven
haplotype tagging DC-SIGN SNPs were
selected. All SNPs are in Hardy–Weinberg
(HW) equilibrium (P.0.05). (b) Pairwise link-
age disequilibrium plot according to Haploview
4.1 for DC-SIGN SNPs. D9 is represented by
colour, changing from red (D951) to dark blue
(D950). D9 is 1 when no recombination has
occurred between two SNPs. The measure of
r2 is represented by a number ranging from 0
to 100. When the minor alleles at two SNP
positions are always present on the same
haplotype, r25100; when the minor alleles are
always on separate haplotypes, r250.
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our knowledge, studies in which our findings could be
replicated are currently lacking. It would therefore be of
high value if newly conducted birth cohort studies on
allergic, but also other, diseases were to incorporate
consecutive faecal sampling throughout the first year of
life. As well as replication of our findings, this could
significantly enhance the possibilities and power to study
host–microbial interaction in health and disease by pooling
data from such studies. In the current molecular era,
incorporation of faecal sampling within such new obser-
vational studies can be achieved relatively easily.
Within the present study no statistically significant gene-
by-environment interactions were found after adjusting for
Table 4. Prevalence of allergic sensitization and AD at age 2 years according to DC-SIGN genotype
DC-SIGN genotype Allergic sensitization
% (cases/total)
AD % (cases/total)
rs11465360 CC 27.9 (120/430) 15.9 (70/441)
CA 29.3 (12/41) 20.9 (9/43)
AA* 50.0 (1/2) 0 (0/2)
P50.85 P50.39
rs11465413 TT 30.0 (124/413) 14.9 (63/423)
TA 17.9 (12/67) 19.7 (14/71)
AA * (1/3) * (1/3)
P50.04 P50.30
rs11465421 AA 29.7 (44/148) 15.2 (23/151)
CA 27.7 (62/224) 14.6 (34/233)
CC 28.3 (30/106) 18.5 (20/108)
P50.91 P50.64
rs2287886 GG 27.1 (54/199) 15.8 (32/203)
(CD209 139 C/T) GA 29.0 (63/217) 16.5 (37/224)
AA 29.7 (19/64) 21.1 (8/66)
P50.88 P50.69
rs4804803 AA 27.7 (88/319) 14.9 (49/328)
(CD209 336 C/T) GA 29.6 (42/142) 15.1 (22/146)
GG 31.8 (7/22) 31.8 (7/22)
P50.86 P50.11
rs4804804 GG 27.6 (56/203) 15.5 (32/207)
(CD209 1466 C/T) GA 28.2 (61/216) 17.0 (38/224)
AA 29.2 (19/65) 11.9 (8/67)
P50.97 P50.61
rs7252229 GG 28.9 (105/363) 14.2 (53/373)
(CD209 216 C/G) CG 23.4 (25/107) 18.9 (21/111)
CC * (5/9) * (5/9)
P50.26 P50.23
rs735239 AA 29.5 (62/210) 17.5 (38/217)
(CD209 871 C/T) GA 27.6 (56/203) 13.9 (29/208)
GG 27.0 (17/63) 14.1(9/64)
P50.88 P50.56
rs735240 GG 30.7 (46/150) 17.5 (27/154)
(CD209 939 C/T) GA 27.0 (61/226) 13.7 (32/234)
AA 28.4 (27/95) 15.5 (15/97)
P50.74 P50.59
rs7359874 TT 31.9 (38/119) 17.9 (22/123)
(CD209 1180 A/T) TA 25.6 (58/227) 14.9 (35/235)
AA 30.2 (39/129) 13.0 (17/131)
P50.40 P50.55
rs8112555 GG 30.5 (110/361) 15.9 (59/371)
(CD209 7882 C/T) GA 19.6 (22/112) 13.8 (16/116)
AA * (5/8) * (3/8)
P50.03 P50.58
*Minor allele homozygotes excluded from x2 tests analyses because of limited number of subjects.
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multiple testing. This may partly be due to the relatively
low number of children with both DNA and faecal
samples available, even though this is one of the largest, if
not the largest, cohort on gut microbial ecology. Further-
more, the low minor allele frequency of this particular
SNP also reduced the power to detect an interaction that
could withstand correction for multiple testing. Whether
the effects of Lactobacillus species on the development of
atopic diseases are modified by genetic variations in DC-
SIGN can therefore not be answered until sample sizes
can be increased significantly by pooling data from new
studies.
The present study was limited in the number of
Lactobacillus species that were targeted: we only examined
five of the 17 Lactobacillus species that can be present in the
human gastrointestinal tract (Walter, 2008). However, we
do not expect to have missed any species that are
commonly found in early infancy. Our results on the
Lactobacillus species composition are in agreement with
several previous studies which consistently showed that
around the age of 1 month L. paracasei, L. acidophilus and
L. rhamnosus (Ahrné et al., 2005; Haarman & Knol, 2006;
Mitsou et al., 2008; Savino et al., 2005) are among the most
prevalent species. In the same studies L. reuteri and L. casei
and several other species were absent or contributed only a
tiny amount to the Lactobacillus microbiota of infants
(Ahrné et al., 2005; Haarman & Knol, 2006; Mitsou et al.,
2008; Savino et al., 2005).
Another drawback of our study is the availability of only
one faecal sample per subject. Caution is therefore due
when particular Lactobacillus species are considered as
lasting (autochthonous) inhabitants. It has so far not been
confirmed that the Lactobacillus species examined in the
present study actually form stable populations. Therefore,
the presence of these species may only indicate the passage
of allochthonous strains. As a consequence, our results may
not be directly comparable with results of clinical trials in
which continuous exposure to the probiotic micro-
organism(s) under study during the intervention period
is assumed to take place at relevant immune surfaces in the
gastrointestinal tract. It is therefore plausible that similar
interactions between the host’s genotype and probiotics
exist and that this could at least partly explain differences
in the results of probiotic trials. It would therefore be of
interest to study the effects of probiotic trials within
specific genetic subgroups. This may also partly resolve
inconsistencies between trials in populations with different
distributions of genetic variants.
In conclusion, the current study shows a decreased risk of
AD in children colonized by L. acidophilus and L. paracasei
and provides evidence that there is an association between
two DC-SIGN SNPs and allergic sensitization.
To further increase our understanding of host–microbial
interactions in health and disease, the incorporation of
consecutive faecal sampling in newly developed (birth)
cohort studies would be a first requisite.
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